Literature DB >> 2794786

Mechanism of intestinal formation of deoxycholic acid from cholic acid in humans: evidence for a 3-oxo-delta 4-steroid intermediate.

I Björkhem1, K Einarsson, P Melone, P Hylemon.   

Abstract

12 alpha-Hydroxy-3-oxo-4-cholenoic acid coupled to an adenosine nucleotide has been shown to be a metabolite of cholic acid in the intestinal anaerobic bacteria, Eubacterium species VPI 12708 (1987. J. Biol. Chem. 262: 4701-4707) and it has been suggested that this may be an intermediate in the conversion of cholic acid into deoxycholic acid. The possibility that the intestinal conversion of cholic acid into deoxycholic acid involves a 3-oxo-delta 4-steroid as an intermediate has been studied in the present work by use of [3 beta-3H]- and [5-3H]-labeled cholic acid. Whole cells as well as cell extracts of Eubacterium sp. VPI 12708 catalyzed conversion of [3 beta-3H] + [24-14C]cholic acid into deoxycholic acid with loss of about 50% of 3H label. When unlabeled chenodeoxycholic acid (20 microM) was added along with [3 beta-3] + [24-14C]cholic acid, then approximately 85% of the [3 beta-3H]-labeled was lost from deoxycholic acid. After administration of the same mixture to two healthy volunteers, deoxycholic acid could be isolated that had lost 81 and 84%, respectively, of the 3H label. Conversion of a mixture of [5-3H]- and [24-14C]labeled cholic acid by the above intestinal bacteria or cell extracts led to loss of 79-94 of the [5-3H] label.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794786

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

Review 1.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease.

Authors:  Tiangang Li; John Y L Chiang
Journal:  Hepatobiliary Surg Nutr       Date:  2020-04       Impact factor: 7.293

2.  Cloning, sequencing, and expression of the gene coding for bile acid 7 alpha-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708.

Authors:  S F Baron; C V Franklund; P B Hylemon
Journal:  J Bacteriol       Date:  1991-08       Impact factor: 3.490

3.  Assessment of fecal bacteria with bile acid 7 alpha-dehydroxylating activity for the presence of bai-like genes.

Authors:  K C Doerner; F Takamine; C P LaVoie; D H Mallonee; P B Hylemon
Journal:  Appl Environ Microbiol       Date:  1997-03       Impact factor: 4.792

Review 4.  Conceptualizing the Vertebrate Sterolbiome.

Authors:  Jason M Ridlon
Journal:  Appl Environ Microbiol       Date:  2020-08-03       Impact factor: 4.792

5.  Investigations of novel unsaturated bile salts of male sea lamprey as potential chemical cues.

Authors:  Nicholas S Johnson; Sang-Seon Yun; Weiming Li
Journal:  J Chem Ecol       Date:  2014-10-30       Impact factor: 2.626

6.  Identification and characterization of a bile acid 7alpha-dehydroxylation operon in Clostridium sp. strain TO-931, a highly active 7alpha-dehydroxylating strain isolated from human feces.

Authors:  J E Wells; P B Hylemon
Journal:  Appl Environ Microbiol       Date:  2000-03       Impact factor: 4.792

7.  Elucidation of the flavonoid catabolism pathway in Pseudomonas putida PML2 by comparative metabolic profiling.

Authors:  Bhinu V S Pillai; Sanjay Swarup
Journal:  Appl Environ Microbiol       Date:  2002-01       Impact factor: 4.792

8.  Characterization of the baiH gene encoding a bile acid-inducible NADH:flavin oxidoreductase from Eubacterium sp. strain VPI 12708.

Authors:  C V Franklund; S F Baron; P B Hylemon
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

Review 9.  Bile Acid Metabolism and Signaling in Cholestasis, Inflammation, and Cancer.

Authors:  Tiangang Li; Udayan Apte
Journal:  Adv Pharmacol       Date:  2015-05-27

10.  Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha/7beta-hydroxy-3-oxo-delta4-cholenoic acid oxidoreductases.

Authors:  Dae-Joong Kang; Jason M Ridlon; Doyle Ray Moore; Stephen Barnes; Phillip B Hylemon
Journal:  Biochim Biophys Acta       Date:  2007-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.